Vulvovaginal candidiasis as a chronic disease: Diagnostic criteria and definition

Journal of Lower Genital Tract Disease

Volumn 18, Issue 1, 2014, Pages 31-38

  Hong, Esther ^a   Dixit, Shreya ^b   Fidel, Paul L ^c   Bradford, Jennifer ^d   Fischer, Gayle ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

candidiasis; chronic; definition; diagnosis; vulvovaginal

Indexed keywords

ADOLESCENT; ADULT; AMBULATORY CARE FACILITIES; AUSTRALIA; CANDIDIASIS, VULVOVAGINAL; CHRONIC DISEASE; CLINICAL MEDICINE; COHORT STUDIES; FEMALE; HUMANS; MICROBIOLOGICAL TECHNIQUES; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84894052580     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0b013e318287aced     Document Type: Article

References (18)

1. Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Candida vaginitis: Self-reported incidence and associated costs. Sex Transmit Dis 2000;27:230-5.
2. Sobel JD. Vulvovaginal candidiasis. Lancet 2007;369: 1961-71.
3. Irving G,Miller D, Robinsons A, Reynolds S, Copas AJ. Psychological factors associated with recurrent vaginal candidiasis: A preliminary study. Sex Transm Infect 1998;74:334-8.
4. Sobel JD. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin Infect Dis 1992;14(suppl 1): S148-53.
5. Sobel JD. Candidal vulvovaginitis. Clin Obstet Gynecol 1993;36:153-65.
6. Powell K. Vaginal thrush: Quality of life and treatments. Br J Nurs 2010;19:1106-11.
7. Finlay AY, Khan GK. Dermatology Life Quality Index. 1991. Available at: Http://www.dermatology.org.uk. Accessed June 2010.
8. Mardh PA, Novikova N, Witkin SS, Korneeva I, Rodriques AR. Detection of Candida by polymerase chain reaction vs microscopy and culture in women diagnosed as recurrent vulvovaginal cases. Int J STD AIDS 2003;14:753-6.
9. Hamad M, Abu-Elteen KH, Ghaleb M. Estrogendependent induction of persistent vaginal candidosis in naBve mice. Mycoses 2004;47:304-309.
10. Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, et al. Vulvovaginal candidiasis: Epidemiologic, diagnostic and therapeutic considerations. Am J Obstet Gynecol 1998;178:203-11.
11. Geiger AM, Foxman B. Risk factors for vulvovaginal candidiasis: A case-control study among university students. Epidemiology 1996;7:182-7.
12. Calderon L, Williams R, Martinez M, Clemons KV, Stevens DA. Genetic susceptibility to vaginal candidiasis. Med Mycol 2003;41:143-7.
13. Fischer G, Bradford J. Vulvovaginal candidiasis in postmenopausal women: The role of hormone replacement therapy. J Low Genit Tract Dis 2011;15:263-7.
14. Dennerstein GJ, Ellis DH. Oestrogen, glycogen and vaginal candidiasis. Aust N Z J Obstet Gynaecol 2001;41:326-8.
15. Fidel PL Jr, Barousse M, Espinosa T, Ficarra M, Sturtevant J, Martin DH, et al. An intravaginal live Candida challenge in humans lead to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infect Immun 2004; 72:2939-46.
16. Nyirjesy P, Peyton C, Weitz MV, Mathew L, Culhane JF. Causes of chronic vaginitis: Analysis of a prospective database of affected women. Obstet Gynecol 2006; 108:1185-91.
17. Redondo-Lopez V, Lynch M, Schmitt CA. Torulopsis glabrata vaginitis: Clinical aspects and susceptibility to antifungal agents. Obstet Gynecol 1990;76:651-5.
18. Donders GG, Bellen G, Mendling W. Management of recurrent vulvo-vaginal candidosis as a chronic illness. Gynecol Obstet Invest 2010;70:306-21.